The coronavirus pandemic has revealed the need for breaking the United States’ dependence on manufacturing in China and other countries.
We’ve long known that China is a dominant source of all manner of products destined for U.S. consumers, but perhaps we weren’t aware of the true nature of that dependency. Turns out, for example, that 80% of all prescription drugs consumed in the U.S. come from China. So do much of the equipment and supplies needed for medical treatment and procedures in this country. But the recent surge of U.S. natural gas production promises to alter that picture. So says Greg Kozera, director of marketing with Shale Crescent USA. He believes the country’s newfound dominance as a supplier of energy can provide the basis for a resurgence of domestic manufacturing — one that will turn around a trend that was decades in the making. But in the face of low-cost competition from abroad, can U.S. production really come back? Hosted by Bob Bowman, Editor-in-Chief of SupplyChainbrain.
Timely, incisive articles delivered directly to your inbox.